Osiris Therapeutics, Inc. (OSIR) Tops Q4 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts OSIR Hot Sheet
Price: $18.99 --0%
Financial Fact:
Income from operations: 310K
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Income from operations: 310K
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Osiris Therapeutics, Inc. (NASDAQ: OSIR) reported Q4 EPS of $0.15, $0.04 better than the analyst estimate of $0.11. Revenue for the quarter came in at $10.28 million versus the consensus estimate of $10.68 million.
For earnings history and earnings-related data on Osiris Therapeutics, Inc. (OSIR) click here.
For earnings history and earnings-related data on Osiris Therapeutics, Inc. (OSIR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CPS Technologies (CPSH) Reports In-Line Q3 EPS
- IREN stock drops on regulatory fears after midterm election
- Alphabet stock jumps as buyers return after selloff
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
